Both studies were conducted in accordance with Good Clinical Practice, the Declaration of Helsinki and US Food and Drug Administration/European Medicines Agency guidelines for studies in people with renal or hepatic impairment [12,13,14,15]
Nature 575 (7784), 688692
Early trials demonstrate that patients experience beneficial weight reduction without severe side effects, which brings optimism to those who need simpler therapeutic options
The cellular GSH is determined by the activity and characteristic of GSH-synthesizing enzymes, energy and precursor supply, and degradation of formed GSH
They can help you interpret changes and support you with strategies that align with safe, healthy, and sustainable progress on your wellness journey